Genetics and Diagnosis: Solving the Puzzle
At a Glance
Diagnosing PLCG2-associated immune disease may require more than a standard genetic panel. Doctors interpret the specific gene change alongside antibody, B-cell, and NK-cell tests, while specialized DNA or immune-cell tests can clarify negative or uncertain results.
Because PLCG2-associated diseases are so rare, the road to a diagnosis often feels like solving a complex puzzle. Confirming the diagnosis requires looking deep into your DNA to find the specific “instruction error” that is causing your immune system to misbehave, and having an expert interpret exactly what that variant means.
The Nature of the Genetic Errors
The PLCG2 gene provides the instructions for an enzyme that helps immune cells communicate. In this disease, the error acts like a glitch in the signaling pathway of your immune cells [1]. There are multiple types of errors, such as:
- Large Deletions and Splice Variants: Many patients with classic PLAID have structural changes in the gene (such as deletions involving specific exons like exon 19). These can cause the enzyme to be relatively quiet at normal body temperature but “wake up” and overreact when the temperature drops, leading to cold-induced hives [2][3].
- Point Mutations: In classic APLAID, the error is often a single “typo” in the DNA code (like the S707Y variant). This typo often keeps the enzyme active, causing constant inflammation regardless of the temperature [4][5]. (Keep in mind, exact variant nomenclature from your lab report matters, and these examples are not categorical rules for every patient).
Gain-of-Function vs. Loss-of-Function
Doctors also look at how the variant affects the enzyme’s power:
- Gain-of-Function (GOF): The enzyme is hyperactive or triggers too easily. This is typical of classic PLAID and APLAID [6].
- Loss-of-Function (LOF): The enzyme is weak or inactive. This produces reduced signaling. While a distinct and heterogeneous phenotype, this can lead to severe immune deficiency (especially against herpesviruses) because the immune cells cannot signal effectively [7][6].
Inheritance and Genetic Counseling
Many reported PLCG2 disorders are autosomal dominant (requiring only one copy of the variant to cause disease), but they can also be de novo (a new mutation not inherited from parents). A clinical geneticist or genetic counselor should review your case to clarify recurrence risk and discuss whether parental testing or family testing is appropriate.
Testing for the Diagnosis
Standard genetic “panels” or exome sequencing (which looks at most of the gene) are very good at finding point mutations (typos). However, depending on the assay design, they might miss the large deletions and “splice-site” errors that can cause PLAID [2].
If your doctor strongly suspects PLCG2 disease but standard tests are negative, they may order more specialized testing, though testing sequences should be directed by a clinical geneticist:
- Targeted Deletion/Duplication Testing
- Whole-Genome Sequencing (WGS): This looks at all of your DNA, including the “dark matter” between genes, to find hidden deletions [2].
- RNA/cDNA Sequencing: This looks at the “messages” the gene sends to the cell. It can help identify if a chunk of the gene is being skipped or deleted [2][8]. WGS and RNA studies have coverage and availability limitations.
Functional Testing: Supportive Evidence
Finding a genetic variant is only half the battle. Sometimes, a lab finds a Variant of Uncertain Significance (VUS)—a change in the DNA that hasn’t been seen before. A VUS should not be treated as a confirmed diagnosis or used alone for predictive family testing or major medical decisions. To provide supportive evidence for a VUS, doctors may use functional testing in specialized research labs, when available [9].
These tests check how your immune cells actually behave:
- Calcium Flux: Scientists measure how much calcium is released inside your B cells when they are stimulated. In many PLCG2 cases, cells release too much calcium, suggesting the enzyme is overactive [6][10].
- ERK Phosphorylation: This test looks at the next step in the cell’s signaling. Abnormal signaling can confirm the variant disrupts internal communication [6][8].
- Temperature Testing: For suspected PLAID, labs may test these signals while cooling the cells down to see if the enzyme responds to cold [3][8].
These functional assays are supportive evidence and must be interpreted with your phenotype, population data, and accepted variant-classification criteria.
The Immune Workup
While the genetic test identifies the cause, an immune evaluation shows the effect on your body. Your doctor will likely order several blood tests:
- B-Cell Subsets: Doctors specifically look for class-switched memory B cells. Many patients have very low levels of these specialized cells, which makes it harder for the body to remember how to fight off specific infections [5][11].
- Quantitative Immunoglobulins: This measures your total antibody levels (IgG, IgA, and IgM). Low levels may mean you need extra protection against bacteria [5][12].
- NK Cell Function: Especially in cases involving a Loss-of-Function variant, your Natural Killer cells may be weak, increasing the risk of viral infections like the one that causes chickenpox or cold sores [7].
- Diagnostic Vaccination: You may be given a non-live vaccine (like the pneumonia shot) and have your blood checked a few weeks later to see if your immune system was able to build a proper defense against it [13].
Common questions in this guide
What kinds of PLCG2 changes can cause PLAID or APLAID?
Can a standard genetic test miss a PLCG2-related disorder?
What does a VUS in PLCG2 mean?
Which immune tests help evaluate PLCG2-associated disease?
Is PLCG2-associated disease inherited?
How can functional testing help evaluate a PLCG2 variant?
Get notified when new evidence is published on PLCG2-associated antibody deficiency and immune dysregulation.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration.
Jackson JT, Mulazzani E, Nutt SL, Masters SL
The Journal of biological chemistry 2021; (297(2)):100905 doi:10.1016/j.jbc.2021.100905.
PMID: 34157287 - 2
Splice site and de novo variants can cause PLCG2-associated immune dysregulation with cold urticaria.
Chou SR, Bailey AC, Baysac K, et al.
The Journal of allergy and clinical immunology 2025; (155(3)):1045-1049.e4 doi:10.1016/j.jaci.2024.06.025.
PMID: 39667583 - 3
Cool-temperature-mediated activation of phospholipase C-γ2 in the human hereditary disease PLAID.
Schade A, Walliser C, Wist M, et al.
Cellular signalling 2016; (28(9)):1237-1251 doi:10.1016/j.cellsig.2016.05.010.
PMID: 27196803 - 4
Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder.
Walliser C, Wist M, Hermkes E, et al.
Oncotarget 2018; (9(76)):34357-34378 doi:10.18632/oncotarget.26173.
PMID: 30344948 - 5
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.
Martín-Nalda A, Fortuny C, Rey L, et al.
Journal of clinical immunology 2020; (40(7)):987-1000 doi:10.1007/s10875-020-00794-7.
PMID: 32671674 - 6
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants.
Baysac K, Sun G, Nakano H, et al.
The Journal of allergy and clinical immunology 2024; (153(1)):230-242 doi:10.1016/j.jaci.2023.08.036.
PMID: 37769878 - 7
Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency.
Alinger JB, Mace EM, Porter JR, et al.
The Journal of allergy and clinical immunology 2024; (153(1)):216-229 doi:10.1016/j.jaci.2023.09.002.
PMID: 37714437 - 8
Splice site and de novo mutations can cause mixed dominant negative/gain of function PLCG2-associated immune dysregulation with cold urticaria (CU-PLAID).
Chou SR, Bailey AC, Baysac K, et al.
medRxiv : the preprint server for health sciences 2024; doi:10.1101/2024.03.16.24304180.
PMID: 38562814 - 9
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Richards S, Aziz N, Bale S, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.
PMID: 25741868 - 10
A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases.
Novice T, Kariminia A, Del Bel KL, et al.
Journal of clinical immunology 2020; (40(2)):267-276 doi:10.1007/s10875-019-00731-3.
PMID: 31853824 - 11
Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2.
Peng Q, Luo D, Yang Y, et al.
Frontiers in immunology 2023; (14()):1014150 doi:10.3389/fimmu.2023.1014150.
PMID: 36776842 - 12
Expanding the clinical features of autoinflammation and phospholipase Cγ2-associated antibody deficiency and immune dysregulation by description of a novel patient.
Morán-Villaseñor E, Saez-de-Ocariz M, Torrelo A, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(12)):2334-2339 doi:10.1111/jdv.15918.
PMID: 31465591 - 13
Value of diagnostic vaccination in diagnosis of humoral inborn errors of immunity.
Hlongwa L, Peter J, Mayne E
Human immunology 2023; (84(5-7)):337-341 doi:10.1016/j.humimm.2023.04.004.
PMID: 37080873
This page is for informational purposes only and does not constitute medical advice. A clinical geneticist and immunologist should interpret PLCG2 test results and guide decisions for your specific situation.